Abstract
Tumor Lysis Syndrome (TLS), a potentially life-threatening complication for patients with cancer, has been subclassified into either laboratory TLS or clinical TLS. Laboratory TLS is characterized by the rapid development of two or more of the following abnormalities – hyperuricemia, hyperkalemia, hyperphospatemia, hypocalcemia, and azotemia – which occur in cancer patients most often 28–72 h after the initiation of chemotherapy or radiation; however, spontaneous cases have been reported [1]. Clinical manifestations of TLS include renal failure (glomerular filtration rate ≤60 ml/min) and organ damage leading to cardiac arrhythmias or seizures. Predisposing factors for TLS include neoplasms with high growth rates, patients with a large tumor size or burden, high white blood cell count (>50,000/mm3), cancers highly sensitive to chemotherapy or radiation, and patients with extensive bone marrow involvement [2]. Comorbidities that increase the risk for developing TLS include elevated uric acid level prior to treatment, preexisting renal insufficiency, obstructive uropathy, and advanced age [2]. Patients with hematological malignancies including high-grade lymphomas (i.e., Burkitt’s lymphoma) and acute or chronic leukemias are more likely to have complications of TLS. In adults with solid tumors, TLS is a rare complication in chemosensitive tumors including bulky small cell lung cancer and metastatic germ cell carcinoma. In children, TLS is more frequently associated with malignancies that have an increased proliferative fraction, large tumor burden, widely metastatic disease, or increased sensitivity to chemotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.